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Objectives: Transplantation of a human trachea has been reported only twice in the
literature with limited documentation of the functional and structural properties of
the allograft.
Patients and Methods: A 57-year-old patient with chronic obstructive pulmonary
disease with low segment tracheal stenosis was accepted for lung transplantation
and 2-stage tracheal allotransplantation. Standard bilateral sequential lung trans-
plantation was performed with the transfer of the donor trachea into the recipient’s
abdomen, which was wrapped in the greater omentum and sutured into the abdom-
inal wall, similar to a stoma. The patient received immunosuppression consisting of
cyclosporine A, mycophenolate mofetil, and cortisone. Sixty days later, the tracheal
allograft presented with macroscopically normal appearance with maintained elas-
ticity and rigidity. The patient underwent a cricotracheal resection 6 months after
lung transplantation. However, reconstruction with direct end-to-end anastomosis
was achievable. The tracheal allograft, therefore not needed for reconstruction, was
harvested and underwent complete investigations.
Results: Cross-section of the graft revealed a mechanically stable and macroscop-
ically intact trachea. Hematoxylin-eosin staining demonstrated vital cartilage cov-
ered by respiratory epithelium. Angiography, followed by corrosion studies and
electromicroscopy, demonstrated excellent vascularization of the tracheal wall.
Conclusion: The patient is alive 31 months posttransplantation and remains in
bronchiolitis obliterans syndrome stage 0. Human trachea wrapped in omentum
maintains its functional and structural integrity and may be used for 2-stage
allotransplantation.
Tracheal transplantation has been investigated for several decades.Contrary to parenchymal organs, the human trachea is supplied by anetwork of small vessels, which makes it inaccessible to directrevascularization.
Although a number of different experimental approaches have been tried in the
search for solutions for this problem, only 2 reports about transplantation of the
trachea in humans have been documented. In 1979, Rose and colleagues 1 reported
the first allogenic tracheal transplantation in a human. The donor trachea was
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implanted heterotopically into the sternocleidomastoid mus-
cle of the recipient and transferred into the orthotopic po-
sition after 3 weeks. In 1993, Levashov2 described a case of
1-stage allotransplantation of the trachea with omentum
wrapping of the graft. Both reports, however, lack a clear
documentation of the viability of the allograft and the func-
tional qualities of its different structures.
This case report documents our experience with hetero-
topic tracheal revascularization by omentum wrapping in
the abdominal position. Ultimately, the graft was not needed
to accomplish tracheal reconstruction; however, minucious
workup demonstrated its structural integrity and suitability
for transfer into the orthotopic position.
Clinical Summary
A 57-year-old man with terminal chronic obstructive pulmonary
disease was referred for lung transplantation. He had a history of
multiple episodes of respiratory failure, resulting in the repeated
need for mechanical ventilation and tracheostomies. Tracheal ste-
nosis developed from these interventions, and multiple treatment
attempts with dilatation and laser ablation had been performed.
It was decided to optimize the tracheal situation first and
reevaluate the necessity for bilateral lung transplantation only
thereafter. At tracheoscopy, the stenotic tracheal segment origi-
nated from the level of the cricoids bow and extended downward
to a total length of 5 cm. A bougienage of the stenosis was
performed, and a Polyflex stent 13 to 50 mm in length (Ruesch
Company, Kernen, Germany) was inserted. This resulted in a
widely open and patent tracheal lumen. However, the patient
remained severely dyspnoic and hypercapnic. The lung function
analysis showed that his FEV1 was 12% predicted and blood gases
were PO2 68 mm Hg and PCO2 56 mm Hg under 3 L of oxygen.
The potential treatment options for the patient were discussed,
which included conservative treatment, bilateral lung transplanta-
tion only, or a combination of bilateral lung transplantation to-
gether with tracheal resection and reconstruction. However, it was
expected that resection and direct end-to-end anastomosis of the
trachea after lung transplantation might become technically diffi-
cult because of the length of the stenotic segment and the limited
mobilization of the trachea after the previous transplantation. It
was therefore decided to offer the patient a staged procedure,
consisting of a bilateral lung transplantation with the transfer of the
donor trachea into the recipient’s abdomen, wrapped in the greater
omentum. This left the option for a later resection of the stenotic
tracheal segment followed by either direct reanastomosis or recon-
struction with the trachea revascularized and pedicled from the
omentum. The choice of this procedure was based on extensive
experimental experience published by others.
After a waiting period of 18 months, a suitable donor (identical
blood group, total lung capacity predicted within 10% range of
recipient, cytomegalovirus constellation [/] identical) became
available. The double lung block was harvested together with the
trachea up to the larynx. The trachea was then separated from the
lungs at the level of the main bronchi, and the bronchi of the lung
allografts were closed with staplers for further procurement. Stan-
dard bilateral sequential lung transplantation was performed
through 2 separate bilateral anterior thoracotomies.
Thereafter, the abdomen was opened by a median laparotomy.
The donor trachea was closed by staplers at 1 end and wrapped in
the distal part of the greater omentum (Figure 1), which was
adapted with single 4-0 PDS stitches (Ruesch Company, Kernen,
Germany) to have close contact with the trachea. The open end of
the trachea was then sutured into the abdominal wall, similar to a
stoma, and the laparotomy was finally closed.
The stoma allowed permanent control of vascularization of the
graft, clearance of secretions during the postoperative period, and
good accessibility for eventual biopsies. In addition, a silicone
stent was loosely inserted into the tracheal graft to prevent any
potential shrinking.
Tracheostomy of the patient was performed at the end of the
operation, and the tracheal stent was removed.
Standard triple immunosuppressive therapy was started with
intravenous cyclosporine A, mycophenolate mofetil, and cortico-
steroids, and was maintained orally thereafter.
The patient was weaned from mechanical ventilation within 5
days and had an uneventful further recovery. After removal of the
tracheal tube, a self-expandable silicone stent (Polyflex, Ruesch
Company) was inserted into the segment at risk to prevent new
stenosis formation.
The tracheal allograft sutured into the abdominal wall was
checked daily. This check included removing the stent, cleaning
any secretions (which eventually were only minor), and inspecting
the mucosal viability. During the first 5 days, there was evidence
of progressive ischemia, with the tracheal mucosa becoming in-
creasingly dark. On postoperative day 6, dark red bleeding from
the mucosa started, followed by a stepwise improvement of the
macroscopic aspect of the mucosa during the next 2 weeks. Sixty
days later the tracheal allograft presented with a macroscopically
normal appearance and maintained rigidity and elasticity of the
cartilaginous tracheal rings.
Figure 1. Donor trachea wrapped in the distal part of the great
omentum.
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The patient was discharged from the hospital on postoperative
day 31. During the further follow-up, recurrent episodes of inflam-
mation around the cervical part of the stent occurred, which made
temporary removal of the stent and intravenous antibiotic therapy
necessary. Developing restenosis, restenting, and recurring epi-
sodes of local infection postponed the definitive attempt to repair
the stenotic segment of the trachea, which finally was performed 8
months after the transplantation.
Through a collar incision, a resection of the 5-cm stenotic
segment of the trachea together with the anterior cricoid cartilage
was performed. The resection was technically difficult because of
enormous calcifications resulting from the previous tracheostomies
and inflammations. However, after meticulous mobilization of the
distal trachea and the larynx, including a suprahyoidal release, a
direct thyroid-cricoid-tracheal end-to-end anastomosis was
achieved.
The heterotopic trachea in the abdomen was therefore ex-
planted. The stoma was incised circumferentially, and an addi-
tional laparotomy was performed, through which the omentum
together with the wrapped trachea was dissected (Figure 2). The
omentum was pedicled, and it was proved that it had enough length
to reach the neck for direct implantation of the trachea. Thereafter,
the allograft together with its omental pedicle was harvested for
further investigations.
Cross-section of the graft revealed a mechanically stable and
macroscopically intact trachea. Hematoxylin-eosin staining re-
vealed vital cartilage covered by respiratory epithelium (Figure 3).
Angiography, followed by corrosion study and electron micros-
copy, demonstrated excellent vascularization of the tracheal wall
(Figure 4).
The patient had an uneventful postoperative recovery and was
discharged from the hospital 6 days after the operation. The
laryngotracheal anastomosis healed well, and no restenosis oc-
curred during the further observation period. The patient remains
in excellent clinical condition 31 months later and currently is in
bronchiolitis obliterans syndrome stage 0.
Figure 4. Respiratory epithelium without signs of rejection.
Figure 2. Dissection of the omentum together with the wrapped
trachea through an additional laparotomy.
Figure 3. Cross-section revealing mechanically stable and mac-
roscopically intact trachea with a histologically vital cartilage.
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Discussion
Transplantation of the human trachea remains an unsolved tech-
nical problem in thoracic surgery. The main reason is the lack of
a well-defined blood supply, which makes direct revascularization
a difficult procedure. An overview of the different, most important
techniques for this specific pathology in thoracic surgery is listed
in Table 1.
Until now, only 2 experimental techniques of direct revascu-
larization have been described in the surgical literature. In 1993,
Khalil-Marzouk and Cooper3 used a composite thyrotracheal allo-
graft in dogs, with anastomoses of the cranial thyroid arteries to the
ipsilateral common carotid arteries, but without venous drainage.
The reported results were promising because 5 of 6 vascularized
and immunosuppressed grafts showed preservation of tracheal
cartilages and surrounding soft tissues. However, the method never
gained further acceptance, because the principles of this technique
were in discordance with the established surgical experience that a
lack of venous drainage ultimately results in infarction of a graft.
Macchiarini and colleagues4 attempted to overcome this limitation
by developing an extensive en bloc technique of thyrotracheal
transplantation in pigs. Harvesting consisted of en bloc cervico-
thoracic exenteration including the aortic arch, supraaortic vessels,
anterior vena cava together with the jugular veins, subclavian
vessels, thyroid glands, and esophagus. Revascularization was
performed by anastomoses of the large arterial and venous vessels.
All tracheal grafts remained viable and had preserved or regener-
ated airway epithelium. However, because of the invasiveness of
the procedure, it has not achieved application in humans.
The alternative approach, to revascularize a tracheal graft in-
directly by wrapping it with viable tissue and stimulating ingrowth
of microvessels, has been intensively investigated in the experi-
mental literature. Preferentially, the greater omentum has been
used, although there are some rare reports about the use of other
tissues like fascia thoracica5,6 or sternocleidomastoideus muscle.1
The reason for this is based in the long-established experience with
the use of omentum in general thoracic surgery, together with the
omentum’s unique features of easy surgical handling and excellent
potential for induction of neoangiogenesis.7 Two different strate-
gies have been applied: orthotopic 1-stage transplantation and
heterotopic transplantation into the abdomen followed by transfer
into the neck at a second stage.
The orthotopic 1-stage technique was initially described by
Baldermann and Weinblatt8 in 1987. Nakanishi and colleagues9
investigated the maximal length of autografts transplanted with
this technique. They were able to demonstrate that grafts longer
than 4 cm frequently showed ischemia in the mid-portion. From
this finding, they concluded that the blood supply to the graft
derived from both ends and the wrapped omentum concomitantly
and that only the synergistic effects of the 2 blood supplies
succeeded in preservation of graft viability at both ends but not at
the mid-portion of the graft.
On the basis of these findings, the “split transplantation of the
trachea” technique, in which the transplanted long segmented
trachea was divided at its mid-portion to facilitate blood vessel
ingrowth, was reported by Yokomise and colleagues.10 No isch-
emia or stenosis was detected after an observation period of 2
months.
However, in clinical reality, autotransplantation is not feasible,
and reduction of alloantigenicity of allotransplants is of impor-
tance. Nakanishi and Yasumoto11 investigated the impact of im-
munosuppression in a heterotopic allotransplant model. They
proved that application of adequate doses of cyclosporine A after
transfer of the donor trachea into the recipient omentum was
effective to prevent allograft rejection and guarantee excellent
healing.
Another approach for reduction of alloantigenicity of a tracheal
transplant was investigated with the use of cryopreserved allo-
grafts.12 With storage at 196°C for 60 days, cartilage viability
was found to be preserved; however, the epithelium was grossly
denudated, and no additional immunosuppression was therefore
needed. Ultimately, longitudinal shrinking of the grafts was ob-
served after a period of 3 months. These findings were confirmed
by Mukaida and colleagues13 and Tojo and colleagues14 who were
able to demonstrate the superiority of cryopreserved allografts to
native ones in the absence of immunosuppression. More recently,
similar evidence was gained in a nonhuman primate model by
Murawaka and colleagues15
The potential advantage of a heterotopic implantation of the
trachea into the omentum in the abdominal position as a first step
was investigated by Li and colleagues.16,17 They resected a 6-ring
segment of trachea and reconstructed it by end-to-end anastomosis
in dogs. The tracheal graft was wrapped in the lower portion of the
omentum. Two weeks later, the omental pedicle, together with the
tracheal graft, was easily brought to the cervical area and sewed
into the former defect. All dogs survived, and the tracheal grafts
maintained their lumen with preserved epithelium and cartilage.
The authors concluded that the prior implantation of tracheal grafts
into the omentum results in better preservation of its structure and
that reconstruction of a tracheal defect with a tracheal graft im-
planted first into the abdomen is feasible.
In contrast with the wide experimental experience, few reports
about tracheal replacement with allografts in humans exist. Most
of the reports describe the use of cryopreserved tracheal ho-
mografts, which were used to reconstruct long segmental stenotic
defects. This procedure, initially developed by Herberhold and
colleagues,18 however, implies that the homografts are split lon-
gitudinally on their posterior portion and that a rim of the native
trachea is preserved and sewed into the defect from where recip-
ient tracheal epithelium grows into the graft. Temporary stenting,
until complete reepithelialization has occurred, is part of the treat-
ment plan, whereas no immunosuppression is necessary because of
reduced immunogenicity. The total North American and world-
wide pediatric experience with this technique was recently re-
viewed by Jacobs and colleagues,19 with 26 of 31 children surviv-
ing and only 1 reported treatment failure.
Except for this elegant approach, which still relies on the
presence of functional tracheal epithelium in the posterior part of
the recipient’s trachea, only 2 cases of allotransplantation of a
whole trachea have been reported. In 1979, Rose and colleagues1
published a report on the heterotopic implantation of a donor
trachea that was wrapped in the sternocleidomastoid muscle and
transferred into the orthotopic position 3 weeks later. Despite the
fact that the authors did not add any immunosuppressive therapy,
a satisfying initial result after 9 weeks was reported, with no
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evidence of rejection, ischemia, or infection. However, no further
information on the long-term results exists.
The second case of human tracheal transplantation was re-
ported by Levashov and colleagues2 in 1993. A 24-year-old female
patient with idiopathic fibrosing mediastinitis, affecting the tho-
racic segment of the trachea, received an allograft replacement of
the distal trachea together with omentum wrapping and cyclospor-
ine A-based immunosuppression. Early rejection after 10 days was
diagnosed and treated with augmented immunosuppression, result-
ing in good functional outcome after 2 months. However, begin-
ning from the fourth postoperative month, progressive stenosis
occurred, and the patient ultimately needed permanent stenting of
the trachea. It remains unclear whether this outcome was the result
of late shrinking of the graft because of ischemia or of underlying
disease progression.
In view of this combined experimental and clinical experience,
it was decided to offer our patient the previously described pro-
cedure. A number of arguments were in favor of this decision.
Most important, the final need for a tracheal transplantation was
unclear at the time of evaluation. Long segmental tracheal stenting
after bilateral lung transplantation was expected to create a signif-
icant risk for recurrent infections. In fact, repeated localized in-
fectious episodes had to be overcome before a definitive repair was
attempted. In addition, the length of the stenotic tracheal segment
would have already been borderline accessible to resection and
direct end-to-end anastomosis in a healthy patient. However, after
bilateral lung transplantation, a significant fixation of the distal
trachea was expected, possibly preventing the necessary mobili-
zation for tension-free end-to-end anastomosis. With the graft
readily available in the abdomen, surgical solutions for all situa-
tions were prepared.
A simultaneous replacement of both lungs and the trachea was
never considered because of all these reasons and the invasiveness
of the procedure.
TABLE 1. Experimental approaches in humans and animals
Experiences in animals Advantages Limitations
Direct vascular anastomosis
Composite thyrotracheal transplant3 Preservation of arterial
blood supply
No venous drainage
Heterotopic thyrotracheal allograft model4 Preservation of arterial and
venous blood supply
Invasiveness of procedure
Indirect revascularization
Omentum wrapping
Orthotopic 1 stage8,11 Limitation in length of
graft (ischemia)
Heterotopic 2 stage17 Preservation of
(Olech et al. Ann Thorac Surg 1991) respiratory
(Borro et al. EJCTS 1992) epithelium
Morphologic excellent
results
Fascial wrapping (Delaere et al. JTCVS 1995)
Split transplantation of the trachea10 Clinical relevance
Sternohyoid muscle wrapping (de Mello- Filho
Laryngoscope 1996)
Experiences in humans
Heterotopic 2-stage sternocleidomastoid wrapping, no
immunosuppression1
No rejection, ischemia,
infection
Lack of histologic
documentation
Orthotopic 1- stage omentum wrapping with IS2 Progressive stenosis
Experiences with cryopreserved allografts (no
immunosuppressants)
Nonhumans13-15
(Moryama et al. Ann Thorac Surg 2000) Reduction of acute
rejection
Shrinking of the grafts;
chronic rejection
No stenosis
Preservation of structural
integrity
Preservation of pars
cartilaginosa
Humans19
(Herberhold et al. EJCTS 1996)
Stenosis and sepsis;
transplantation only of
pars cartilaginosa
Encouraging short- to
medium-term results;
expectation of good
long-term results
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To offer the patient the highest possible safety, we created an
abdominal stoma with 1 end of the graft, which allowed permanent
check of the tracheal vascularization and the possibility of insert-
ing a silicon stent. How important this stent really was for pre-
vention of allograft shrinking remains unclear. In fact, a minimal
longitudinal shortening of the graft was observed at the time of
harvesting, although this was not precisely measured.
The final analysis of the explanted allograft evidenced the
viability and structural integrity of the heterotopic transplanted
trachea. In addition, the feasibility for a transfer of the pedicled
graft into the cervical region was proven. However, from this
experience, the minimal level of immunosuppression needed in
humans for prevention of tracheal graft rejection remains unclear,
because this patient received routine triple drug therapy at a level
comparable to that received by other lung transplant patients.
Conclusion
This is the first human case of heterotopic tracheal allotransplan-
tation and omentum wrapping in the abdomen. All necessary
prerequisites for a final transfer of the graft into the orthotopic
position were sufficiently achieved. This experience could serve as
a model for a planned tracheal transplantation in treating long
extending, nonmalignant tracheal problems.
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